TELA Bio financials at a glance

+ Portfolio

The revenue of TELA Bio is reported as 0.05845 billion Dollars in the fiscal year 2023. The earnings were -2.04 Dollars per share in 2023, which was 23.02 higher than 2022. And about -0.0002 billion Dollars are reported as free cash flow in the financials of TELA Bio 2023. No dividends were paid to the shareholders of the TELA Bio stock NasdaqGM:TELA in the financial year 2023.

$58.45M

Revenue

$-2.04

Earnings Per Share

69.27%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

58.45

Earnings Per Share

-2.04

Gross Margin %

69.27

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019
Rev.	Revenue	N/A	$58.45M	$41.42M	$29.46M	$18.21M	$15.45M
GM %	Gross Margin %	69.79%	69.27%	67.24%	64.88%	63.35%	62.00%
OM	Operating Margin	-77.69%	-75.40%	-94.18%	-99.96%	-,138.77%	-,124.06%
EPS	Earnings Per Share	$-2.03	$-2.04	$-2.65	$-2.30	$-2.23	$-1.97
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0
Sha.	Shares	N/AM	24.65M	19.22M	14.55M	14.44M	11.41M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$-25.52M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$-25.72M
FCFS	Free Cash Flow Per Share	$-1.96	$-1.81	$-2.62	$-2.15	$-1.90	$-15.98

TELA Bio financials at a glance

Financials

Discover